Cisplatin in the modern era: The backbone of first-line chemotherapy for non-small cell lung cancer
DA Fennell, Y Summers, J Cadranel, T Benepal… - Cancer treatment …, 2016 - Elsevier
The treatment of advanced non-small cell lung cancer (NSCLC) may be changing, but the
cisplatin-based doublet remains the foundation of treatment for the majority of patients with …
cisplatin-based doublet remains the foundation of treatment for the majority of patients with …
Platinum-based chemotherapy in advanced non-small-cell lung cancer: optimal number of treatment cycles
A Rossi, M Di Maio - Expert review of anticancer therapy, 2016 - Taylor & Francis
Platinum-based chemotherapy remains the standard-of-care for most patients affected by
advanced non-small cell lung cancer (NSCLC). The platinum compounds currently used in …
advanced non-small cell lung cancer (NSCLC). The platinum compounds currently used in …
Cisplatin-versus carboplatin-based chemotherapy in first-line treatment of advanced non–small-cell lung cancer: an individual patient data meta-analysis
A Ardizzoni, L Boni, M Tiseo, FV Fossella… - Journal of the …, 2007 - academic.oup.com
Background Because the efficacy of carboplatin and cisplatin in the treatment of advanced
non–small-cell lung cancer (NSCLC) has not been proven to be equivalent, an individual …
non–small-cell lung cancer (NSCLC) has not been proven to be equivalent, an individual …
[HTML][HTML] Efficacy and safety of first-line carboplatin-versus cisplatin-based chemotherapy for non-small cell lung cancer: A meta-analysis
F Griesinger, EE Korol, S Kayaniyil, N Varol, T Ebner… - Lung Cancer, 2019 - Elsevier
Objectives Platinum-based chemotherapy is the mainstay of first-line (1L) therapy for
advanced non-small cell cancer (NSCLC). The objective of this study was to evaluate the …
advanced non-small cell cancer (NSCLC). The objective of this study was to evaluate the …
Platinum drugs in the treatment of non-small-cell lung cancer
J Cosaert, E Quoix - British journal of cancer, 2002 - nature.com
The use of chemotherapy is considered standard therapy in patients with locally advanced
non-small-cell lung cancer that cannot be treated with radiotherapy and in those with …
non-small-cell lung cancer that cannot be treated with radiotherapy and in those with …
The expanding role of cisplatin in the treatment of non-small-cell lung cancer.
PA Bunn Jr - Seminars in oncology, 1989 - europepmc.org
Cisplatin has been employed in the treatment of non-small-cell lung cancer (NSCLC) since
the late 1970s. Current evidence suggests that it may be the most effective single drug for …
the late 1970s. Current evidence suggests that it may be the most effective single drug for …
Meta-analysis of randomized clinical trials comparing cisplatin to carboplatin in patients with advanced non–small-cell lung cancer
K Hotta, K Matsuo, H Ueoka, K Kiura… - Journal of Clinical …, 2004 - ascopubs.org
Purpose It remains undetermined whether cisplatin and carboplatin are equally effective for
advanced non–small-cell lung cancer (NSCLC). We therefore did a meta-analysis of trials …
advanced non–small-cell lung cancer (NSCLC). We therefore did a meta-analysis of trials …
Molecular basis of cellular response to cisplatin chemotherapy in non-small cell lung cancer
G Wang, E Reed, QQ Li - Oncology reports, 2004 - spandidos-publications.com
Cisplatin is one of the most potent anticancer agents, displaying significant clinical activity
against a variety of solid tumors. For more than two decades, the most effective systemic …
against a variety of solid tumors. For more than two decades, the most effective systemic …
Chemotherapy, chemoresistance and the changing treatment landscape for NSCLC
A Chang - Lung cancer, 2011 - Elsevier
Management of patients with lung cancer continues to pose a considerable challenge to
today's oncologist. While treatment may be curative in the early stages of the disease, the …
today's oncologist. While treatment may be curative in the early stages of the disease, the …
State-of-the-art chemotherapy for advanced non-small cell lung cancer
S Ramalingam, CP Belani - Seminars in oncology, 2004 - Elsevier
The treatment of advanced non-small cell lung cancer (NSCLC) has continued to evolve
over recent years. We have moved from an era of therapeutic nihilism to optimism, largely …
over recent years. We have moved from an era of therapeutic nihilism to optimism, largely …
相关搜索
- lung cancer meta analysis
- lung cancer cisplatin in the treatment
- lung cancer platinum drugs
- lung cancer carboplatin in patients
- molecular basis cisplatin chemotherapy
- lung cancer combination of paclitaxel
- lung cancer optimal number
- cellular response cisplatin chemotherapy
- lung cancer cisplatin in patients
- lung cancer paclitaxel and cisplatin
- lung cancer treatment cycles